|
1
|
Harvey J and Warwick I: Endometriosis.
BMJ. 340:c26612010. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Korzekwa A, Łupicka M, Socha B, Mannelli
Ch and Skarzynski DJ: Is adenomyosis a problem in reproduction and
fertility? Pol J Vet Sci. 17:187–194. 2014.PubMed/NCBI
|
|
3
|
Farquhar C and Brosens I: Medical and
surgical management of adenomyosis. Best Pract Res Clin Obstet
Gynaecol. 20:603–616. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lousse JC, Van Langendonckt A, Defrere S,
Ramos RG, Colette S and Donnez J: Peritoneal endometriosis is an
inflammatory disease. Front Biosci (Elite Ed). 4:23–40. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sheldon IM and Bromfield JJ: Innate
immunity in the human endometrium and ovary. Am J Reprod Immunol.
66 Suppl 1:S63–S71. 2011. View Article : Google Scholar
|
|
6
|
Bertschi D, McKinnon BD, Evers J,
Bersinger NA and Mueller MD: Enhanced inflammatory activity of
endometriotic lesions from the rectovaginal septum. Mediators
Inflamm. 2013:4509502013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo J, Chen L, Luo N, Li C, Chen R, Qu X,
Liu M, Kang L and Cheng Z: LPS/TLR4-mediated stromal cells acquire
an invasive phenotype and are implicated in the pathogenesis of
adenomyosis. Sci Rep. 6:214162016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan L, Wang W, Shi F, Zhou J, Zhang M, Zhu
H and Zeng M: Exploratory pharmacokinetics of Geniposide in rat
model of cerebral ischemia orally administered with or without
Baicalin and/or Berberine. Evid Based Complement Alternat Med.
2013:3495312013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Y, Xun K, Wang Y and Chen X: A
systematic review of the anticancer properties of berberine, a
natural product from Chinese herbs. Anticancer Drugs. 20:757–769.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kong WJ, Zhang H, Song DQ, Xue R, Zhao W,
Wei J, Wang YM, Shan N, Zhou ZX, Yang P, et al: Berberine reduces
insulin resistance through protein kinase C-dependent up-regulation
of insulin receptor expression. Metabolism. 58:109–119. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh IP and Mahajan S: Berberine and its
derivatives: A patent review (2009–2012). Expert Opin Ther Pat.
23:215–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin J, Zhang H and Ye J: Traditional
chinese medicine in treatment of metabolic syndrome. Endoc Metab
Immune Disord Drug Targets. 8:99–111. 2008. View Article : Google Scholar
|
|
13
|
Jin P, Zhang C and Li N: Berberine
exhibits antitumor effects in human ovarian cancer cells.
Anticancer Agents Med Chem. 15:511–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Cao B, Liu X, Fu X, Xiong Z, Chen L,
Sartor O, Dong Y and Zhang H: Berberine suppresses androgen
receptor signaling in prostate cancer. Mol Cancer Ther.
10:1346–1356. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ,
Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, et al: Berberine, a natural
plant product, activates AMP-activated protein kinase with
beneficial metabolic effects in diabetic and insulin-resistant
states. Diabetes. 55:2256–2264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Q, Qin R, Fang Y and Li H: Berberine
sensitizes human ovarian cancer cells to cisplatin through
miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem.
36:956–965. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marverti G, Ligabue A, Lombardi P, Ferrari
S, Monti MG, Frassineti C and Costi MP: Modulation of the
expression of folate cycle enzymes and polyamine metabolism by
berberine in cisplatin-sensitive and -resistant human ovarian
cancer cells. Int J Oncol. 43:1269–1280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Exacoustos C, Manganaro L and Zupi E:
Imaging for the evaluation of endometriosis and adenomyosis. Best
Pract Res Clin Obst Gynaecol. 28:655–681. 2014. View Article : Google Scholar
|
|
19
|
Rajaei S, Mirahmadian M, Jeddi-Tehrani M,
Tavakoli M, Zonoobi M, Dabbagh A and Zarnani AH: Effect of
1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of
women with repeated implantation failure. Gynecol Endocrinol.
28:906–911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wan L, Zou Y, Wan LH, Wang LQ, Huang MZ,
Wu J, Zhu YB and Huang OP: Tanshinone IIA inhibits the
proliferation, migration and invasion of ectopic endometrial
stromal cells of adenomyosis via 14-3-3zeta downregulation. Arch
Gynecol Obstet. 292:1301–1309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS
and Ho HN: Altered apoptosis and proliferation in endometrial
stromal cells of women with adenomyosis. Hum Reprod. 22:945–952.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bruse C, Guan Y, Carlberg M, Carlström K
and Bergqvist A: Basal release of urokinase plasminogen activator,
plasminogen activator inhibitor-1, and soluble plasminogen
activator receptor from separated and cultured endometriotic and
endometrial stromal and epithelial cells. Fertil Steril. 83 Suppl
1:S1155–S1160. 2005. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miller SI, Ernst RK and Bader MW: LPS,
TLR4 and infectious disease diversity. Nat Rev Microbiol. 3:36–46.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu YC, Yeh WC and Ohashi PS: LPS/TLR4
signal transduction pathway. Cytokine. 42:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Azuma Y, Taniguchi F, Nakamura K, Nagira
K, Khine YM, Kiyama T1, Uegaki T, Izawa M and Harada T:
Lipopolysaccharide promotes the development of murine
endometriosis-like lesions via the nuclear factor-kappa B pathway.
Am J Reprode Immunol. 77:2017.
|
|
27
|
Allhorn S, Böing C, Koch AA, Kimmig R and
Gashaw I: TLR3 and TLR4 expression in healthy and diseased human
endometrium. Reprod Biol Endocrinol. 6:402008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chu M, Ding R, Chu ZY, Zhang MB, Liu XY,
Xie SH, Zhai YJ and Wang YD: Role of berberine in anti-bacterial as
a high-affinity LPS antagonist binding to TLR4/MD-2 receptor. BMC
Complement Alternat Med. 14:892014. View Article : Google Scholar
|
|
29
|
Huang LH, Pan XP, Gong KR and Shao G:
Anti-inflammatory effects of three kinds of traditional Mongolian
medicine monomer and its combination on LPS-stimulated RAW264.7
macrophages. Eur Rev Med Pharmacol Sci. 20:950–958. 2016.PubMed/NCBI
|
|
30
|
Li HM, Wang YY, Wang HD, Cao WJ, Yu XH, Lu
DX, Qi RB, Hu CF and Yan YX: Berberine protects against
lipopolysaccharide-induced intestinal injury in mice via alpha 2
adrenoceptor-independent mechanisms. Acta Pharmacol Sin.
32:1364–1372. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Benagiano G, Brosens I and Habiba M:
Structural and molecular features of the endomyometrium in
endometriosis and adenomyosis. Hum Reprod Update. 20:386–402. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang JH, Chen MJ, Wu MY, Chen YC, Yang YS
and Ho HN: Decreased suppression of interleukin-6 after treatment
with medroxyprogesterone acetate and danazol in endometrial stromal
cells of women with adenomyosis. Fertil Steril. 86:1459–1465. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
May KE, Conduit-Hulbert SA, Villar J,
Kirtley S, Kennedy SH and Becker CM: Peripheral biomarkers of
endometriosis: A systematic review. Hum Reprod Update. 16:651–674.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Younis A, Hawkins K, Mahini H, Butler W
and Garelnabi M: Serum tumor necrosis factor-α, interleukin-6,
monocyte chemotactic protein-1 and paraoxonase-1 profiles in women
with endometriosis, PCOS, or unexplained infertility. J Assist
Reprod Genet. 31:1445–1451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khan KN, Masuzaki H, Fujishita A, Kitajima
M, Hiraki K, Sekine I, Matsuyama T and Ishimaru T: Interleukin-6-
and tumour necrosis factor alpha-mediated expression of hepatocyte
growth factor by stromal cells and its involvement in the growth of
endometriosis. Hum Reprod. 20:2715–2723. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sotnikova N, Antsiferova I and Malyshkina
A: Cytokine network of eutopic and ectopic endometrium in women
with adenomyosis. Am J Reprod Immunol. 47:251–255. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Omwandho CO, Konrad L, Halis G, Oehmke F
and Tinneberg HR: Role of TGF-betas in normal human endometrium and
endometriosis. Hum Reprod. 25:101–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kang S, Zhao J, Liu Q, Zhou R, Wang N and
Li Y: Vascular endothelial growth factor gene polymorphisms are
associated with the risk of developing adenomyosis. Environ Mol
Mutagen. 50:361–366. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang JH, Wu MY, Chen MJ, Chen SU, Yang YS
and Ho HN: Increased matrix metalloproteinase-2 and tissue
inhibitor of metalloproteinase-1 secretion but unaffected
invasiveness of endometrial stromal cells in adenomyosis. Fertil
Steril. 91 5 Suppl:2193–2198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yi KW, Kim SH, Ihm HJ, Oh YS, Chae HD, Kim
CH and Kang BM: Increased expression of p21-activated kinase 4 in
adenomyosis and its regulation of matrix metalloproteinase-2 and −9
in endometrial cells. Fertil Steril. 103:1089–1097.e2. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Weigel MT, Krämer J, Schem C, Wenners A,
Alkatout I, Jonat W, Maass N and Mundhenke C: Differential
expression of MMP-2, MMP-9 and PCNA in endometriosis and
endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 160:74–78.
2012. View Article : Google Scholar : PubMed/NCBI
|
